Replies to post #12149 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Thanks Ignatius. Well that strategy is getting more risky, as evidenced by the 2m shares covered in the last two months. DO knows the stock has been held hostage by shorts. And given that ADXS management is now fully loaded and secured three year options grant at a low strike price in October, I would imagine at some point moving forward DO's execution of the business plan will involve catalysts that contribute to a large unwinding of short interest and resetting our valuation up to fair value because ultimately it's in everyone's interest (except shorts) for DO to generate shareholder value. 2017 appears to be a turning point...